| Literature DB >> 36188840 |
Jamie F Mayer1, Chaleece W Sandberg2, Jennifer Mozeiko3, Elizabeth B Madden4, Laura L Murray5.
Abstract
This systematic review aimed to determine how aerobic exercise affects cognition after stroke, with particular focus on aphasia and language improvement. Methodological quality was assessed with the PEDro+ scale with half of the 27 included studies rated as high quality. Data extraction focused on cognitive effects of aerobic exercise post-stroke, intervention characteristics, outcome measures, and participant characteristics. Whereas attention, memory, and executive functioning measures were common across the included studies, no study included a language-specific, performance-based measure. Seventeen studies reported positive cognitive effects, most frequently in the domains of attention, memory and executive functioning. Variability in outcome measures, intervention characteristics, and participant characteristics made it difficult to identify similarities among studies reporting positive cognitive effects of exercise or among those studies reporting null outcomes. Only three studies provided specific information about the number of individuals with aphasia included or excluded, who comprise approximately one-third of the stroke population. The review identified patent gaps in our understanding of how aerobic exercise may affect not only the cognitive domain of language post-stroke but also the broader cognitive functioning of individuals with post-stroke aphasia. Methodological limitations of the reviewed studies also warrant further examination of the direct impact of aerobic exercise on cognition post-stroke with careful attention to the selection and reporting of population, intervention, and outcomes.Entities:
Keywords: aerobic exercise; aphasia; cognition; language; rehabilitation; stroke
Year: 2021 PMID: 36188840 PMCID: PMC9397720 DOI: 10.3389/fresc.2021.785312
Source DB: PubMed Journal: Front Rehabil Sci ISSN: 2673-6861
Figure 1Prisma diagram generated from Covidence.
Design and PEDro+ Score of included studies.
|
|
|
|
|
|---|---|---|---|
| 1 | RCT | 8 | |
| 2 | Chan and Tsang ( | RCT | 8 |
| 3 | non-randomized controlled trial | 4 | |
| 4 | case-control study | 6 | |
| 5 | prospective cohort | 5 | |
| 6 | RCT | 7 | |
| 7 | RCT | 9 | |
| 8 | RCT | 7 | |
| 9 | prospective cohort | 3 | |
| 10 | Krawcyk et al. ( | RCT | 8 |
| 11 | prospective cohort | 4 | |
| 12 | Macko et al. ( | prospective cohort | 4 |
| 13 | prospective cohort | 4 | |
| 14 | RCT | 5 | |
| 15 | Meester et al. ( | RCT | 6 |
| 16 | RCT | 9 | |
| 17 | prospective cohort | 3 | |
| 18 | Pallesen et al. ( | RCT | 8 |
| 19 | Ploughman et al. ( | RCT crossover | 6 |
| 20 | Ploughman et al. ( | RCT | 10 |
| 21 | Quaney et al. ( | RCT | 7 |
| 22 | RCT | 8 | |
| 23 | Stuart et al. ( | non-randomized controlled trial | 8 |
| 24 | interrupted time series | 5 | |
| 25 | Tang et al. ( | RCT | 8 |
| 26 | non-randomized controlled trial | 5 | |
| 27 | RCT | 9 |
Studies that showed positive cognitive effects of aerobic exercise. RCT, randomized controlled trial. The study number in this table is used to identify these articles in the remaining tables.
Figure 2PEDro+ Scale item reporting.
Figure 3Effects broken down by outcome measures and cognitive domains. (A) Proportion of studies that utilized the outcome measures identified in this review, averaged across outcome measures (e.g., the Stroop task was included in 6 of the 27 studies). This emphasizes the variability in the outcome measures chosen across studies. (B) Average (across outcome measures) of the proportion of studies that used the outcome measure and showed an effect vs. no effect (e.g., among the six studies using the Stroop task, five showed no effect). The numbers do not add up to 100% because many measures were only reported in one study. (C) Domains of outcome measures that showed an effect. Each domain contains measures that contribute to that domain and the number of studies that showed an effect on that measure. The “composite” domain represents effects for which only the composite score on cognitive screeners was reported. See Supplementary Table 4 for test abbreviations.
Participant characteristics in reviewed studies.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| |||||
| 1 | 42 | 65.12 | 23/19 | >6 | NR |
| 3 | 15 | 57.3 | 4/11 | 44 (28.9) | SAH; 4 RMCA, 3 LMCA, 3 RpComm, 3 LaComm, 1 RaComm |
| 4 | 15 | 48.4 | NR | 3-18 | anterior ischemic stroke |
| 5 | 34 | 64.6 | 19/15 | 3.5 (1.1) | 19 RH, 15 LH; 26 ischemic, 8 hemorrhagic |
| 6 | 177 | 71.4 | 99/78 | NR | 163 infarction; 14 hemorrhage |
| 7 | 22 | 65.9 | 13/9 | 39.6 (48.0) | 15 RH, 10 LH; 3 lacunar, 7 ischaemic, 9 hemorrhagic, 6 unknown |
| 8 | 14 | 50.71 | 9/5 | 12.79 (7.34) | NR |
| 9 | 9 | 63.7 | 5/4 | 50.4 (37.9) | 3 RH, 6 LH |
| 11 | 28 | 56.74 | all M | 26.04 (19.08) | 8 RH, 20 LH; all ischemic |
| 13 | 41 | 63.6 | 30/11 | >10 weeks | 65.9% ischemic |
| 14 | 17 | 70.1 | 12/5 | 106.8 (CI = 67.2, 146.4) | 52% LH; 82% ischemic |
| 16 | 20 | 68 | 18/2 | 21 ( | 10 RH, 9 LH, 1 bilateral; 1 hemorrhagic; 5 cortical, 4 BG, 2 cerebellar, 7 subcortical other, 2 unknown |
| 17 | 11 | 69.6 | 7/4 | NR | 5 ischemic, 6 hemorrhagic |
| 22 | 32 | 55.5 | 22/10 | 14 (average median) | NR |
| 24 | 9 | 57.8 | 6/3 | 37.6 ( | 7 RH, 2 LH; 6 ischemic, 1 ischemic and hemorrhagic (2 unreported) |
| 26 | 15 | 58.43 | 10/5 | 1-12 | 11 RH, 4 LH; 10 ischemic, 5 hemorrhagic |
| 27 | 28 | 60.86 | 17/11 | 66.6 (21.6) | 17 RH, 11 LH |
|
| |||||
| 2 | 17 | 62.7 | 10/7 | 93.6 (73.2) | 7 RH, 10 LH; 11 ischemic, 5 hemorrhagic, 1 both |
| 10 | 31 | 63.7 | 23/8 | NR | 19 RH, 12 LH; lacunar: 17 BG, 9 thalamus |
| 12 | 20 | 70 | 9/11 | 56 ( | NR |
| 21 | 62.25 | 11/10 | 25.71 (32.70) | 13 RH, 6 LH, 5 midbrain; 13 ischemic, 10 hemorrhagic, 1 both | |
| 18 | 16 | 55 | 9/7 | NR | 6 RH, 8 LH, 2 (unknown); 13 CVA, 3 SAH |
| 19 | 21 | 61.4 | 13/8 | 20.1 (14.6) | 19 ischemic, 2 hemorrhagic; 6 cortical, 11 subcortical, 3 both, 1 brainstem |
| 13 | 58.4 | 9/4 | 36.0 (53.4) | 6 RH, 6 LH, 1 bilateral; 12 ischemic, 1 hemorrhagic | |
| 21 | 19 | 64.1 | 10/9 | 55.44 (38.52) | all ischemic |
| 23 | 40 | 66.6 | 25/15 | 50.4 (9.6) | 26 RH, 14 LH |
| 25 | 25 | 66 | 14/11 | 42 (range: 26.4-80.4) | 15 RH, 10 LH; 3 lacunar, 7 ischemic, 9 hemorrhagic, 6 unknown; 4 cortical, 7 subcortical, 5 brainstem, 9 unknown |
Studies that included PWA; NR, not reported; RH, right hemisphere; LH, left hemisphere; CVA, cerebrovascular accident; PWA, persons with aphasia; SAH, subarachnoid hemorrhage; BG, basal ganglia; aComm, anterior communicating artery; pComm, posterior communicating artery.
Intervention characteristics in studies reviewed.
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| 1 | Group | Aerobic + Resistance | Moderate | BPES 13-15 | jogging, cycling, strength, balance | Supervised | 50 m ×3 d/w | 150 | 12 w |
| 3 | Individual | Aerobic | Moderate to High | 55-85% HRmax | walking | Both | 30-45 m ×3-5 d/w | 90-225 | 12 w |
| 4 | Group | Aerobic + Resistance | NR | NA | PT + cycling | Supervised | 30 m PT + 45 m aerobic ×3 d/w | 135 | 8 w |
| 5 | Individual | Aerobic | NR | 6,000+ steps/day | STUFFS, walking | Unsupervised | NR | NR | 8 w |
| 6 | Individual | Aerobic | Goal: High | Self-report | individualized: any physical activity 30 m/d + “vigorous” activity 2-3 d/w | Unsupervised | 30 m/d active + 45-60 m vigorous ×2-3 d/w | 90-180 | 72 w |
| 7 | Group | Aerobic | Moderate to High | 40-80% HRmax | walking, cycling, marching, sit-to-stand, platform steppers | Supervised | 60 m ×3 d/w | 180 | 24 w |
| 8 | NR | Aerobic + Resistance | NR | NA | handgrip exercise + walking (treadmill) | Supervised | 15 m strength + 20 m walking ×5 d/w | 100 | 6 w |
| 9 | Group | Aerobic + Resistance | Light to Moderate | 50% VO2max | TBRS + resistance training (bands) of lower extremities | Supervised | 60 m ×3 d/w | 180 | 12 w |
| 11 | Group | Aerobic + Resistance | Moderate | 60% VO2reserve | cycling + strength | Supervised | 55 m aerobic ×3 d/w + strength ×2 d/w | 165 | 24 w |
| 13 | Both | Aerobic + Resistance | Moderate | 40-70% HRreserve/ VO2max; BPES 11-16 | walking, stationary recumbent, upright cycling | Both | 20-60 m ×5 d/w | 100-300 | 24 w |
| 14 | Group | Aerobic + Resistance | NR | NA | aerobic circuit class + resistance training | Supervised | 60 m ×1-2 d/w | 60-120 | 24 w |
| 16 | Group | Aerobic + Resistance | Light to Moderate | 40-80% HRmax | FAME: strength, balance, walking/jogging, marching | Supervised | 45-60 m ×3 d/w | 135-180 | 19 w |
| 17 | NR | Aerobic | Moderate | 40% VO2max | Ergometer | Supervised | 15 m ×1 session | NA | NA |
| 22 | Group | Aerobic + Resistance | Moderate to High | 60-80% HRreserve | recumbent cycling + UE-RTP | Supervised | 45 m ×24 sessions | NR | NR |
| 24 | NR | Aerobic | Moderate | 45-55% HRreserve | semi-recumbent stepper | Supervised | 20 m ×1 session | NA | NA |
| 26 | Group | Aerobic | NR | NA | Nintendo Wii Sports Resort: archery, tennis, golf, bowling, cycling, air sports | Supervised | 30 m ×3 d/w | 90 | 8 w |
| 27 | Group | Aerobic + Resistance | NR | NA | walking + functional UE tasks (theraband, armcycle, lifting weighted box) | Both | 90 m ×3 d/w | 270* | 24 w |
|
| |||||||||
| 2 | Group | Aerobic + Resistance | NR | NA | walking + seated stretching and strengthening | Supervised | 60 m ×2 d/w | 120 | 12 w |
| 10 | Individual | Aerobic | High | 77-93% HRmax; BPES 14-16 | Home-based HIIT, self-chosen exercise modality; provided stationary bike if needed | Unsupervised | 3 ×3 m + 2 m “active recovery,” 5 d/w | 55 | 12 w |
| 12 | Group | Aerobic | NR | NA | walking with handrail support, weight-shifting, ROM | Supervised | 60 m ×2 d/w | 120 | 8 w |
| 15 | Individual | Aerobic | Moderate to high | 55-85% HRmax | treadmill walking | Supervised | 45 m ×2 d/w | 90 | 10 w |
| 18 | Group | Aerobic | Moderate to high | >70% HRmax | cycling, platform stepper, sit-to-stand | Supervised | 50 m ×2 d/w | 100 | 4 w |
| 19 | NR | Aerobic | Moderate | 70% HRmax | treadmill walking | Supervised | 20 m ×2 sessions | NR | NR |
| 20 | Group | Aerobic | Light to moderate | 60% VO2max | treadmill walking | Supervised | 60 m ×3 d/w | 180 | 10 w |
| 21 | Group | Aerobic | Moderate | 70% HRmax | stationary bike | Supervised | 45 m ×3 d/w | 135 | 8 w |
| 23 | Group | Aerobic + Resistance | NR | NA | APA: walking, strength, balance | Supervised | 60 m ×3 d/w | 180 | 24 w |
| 25 | Group | Aerobic | Moderate to high | 40-80% HRreserve | individualized aerobic training (modality NR) | Supervised | 60 m ×3 d/w | 180 | 24 w |
NR, not reported; NA, not applicable; BPES, Borg Perceived Exertion Scale; STUFFS, Stand up Frequently from Stroke; PT, physical therapy; TBRS, Total Body Recumbent Stepper; FAME, Fitness and Mobility Exercise Program; UE-RTP, upper extremity repetitive task practice; HIIT, High Intensity Interval Training; ROM, range of motion; APA, Adaptive Physical Activity stroke program; HRmax, maximum heart rate; HRreserve, heart rate reserve (difference between maximum and resting heart rate); VO2max, maximal oxygen uptake; VO2reserve, oxygen uptake reserve (difference between maximum and resting oxygen uptake); d/w, days per week; m, minutes.